Related Experiment Video
Updated: Jan 4, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
CAKUT and Autonomic Dysfunction Caused by Acetylcholine Receptor Mutations.
Nina Mann1, Franziska Kause1, Erik K Henze2
1Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Mutations in the CHRNA3 gene cause bladder dysfunction, leading to congenital anomalies of the kidney and urinary tract (CAKUT) and dysautonomia. This research identifies a novel genetic cause for these complex conditions.
Area of Science:
- Genetics
- Nephrology
- Developmental Biology
Background:
- Congenital anomalies of the kidney and urinary tract (CAKUT) are a leading cause of chronic kidney disease.
- In utero urinary obstruction frequently leads to secondary upper urinary tract malformations.
Purpose of the Study:
- To investigate the genetic basis of functional lower urinary tract obstruction and secondary CAKUT.
- To identify novel genes associated with bladder dysfunction and related congenital anomalies.
Main Methods:
- Whole-exome sequencing was performed on affected individuals from three families.
- Functional in vitro studies assessed the impact of identified mutations on nicotinic acetylcholine receptor function and localization.
Main Results:
- Three distinct biallelic mutations in CHRNA3, encoding the nicotinic acetylcholine receptor alpha-3 subunit, were identified in five individuals.
- Mutant receptors showed impaired acetylcholine-stimulated current generation and reduced plasma membrane localization.
- Affected individuals exhibited lower urinary tract obstruction, secondary CAKUT, and in some cases, dysautonomia.
Conclusions:
- Mutations in CHRNA3 are a novel cause of bladder dysfunction, leading to secondary CAKUT and dysautonomia.
- This study highlights the critical role of acetylcholine signaling in bladder innervation and development.
- Monogenic mutations affecting bladder innervation can secondarily cause CAKUT, revealing a new pathophysiological pathway.
Related Concept Videos
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

